Robert Otto, MD
Orthopaedic Surgery · Nashville, TNNPI 1003013947
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $55,299 of the $76,612 with a category attached, or 72.2%. Exactech, Inc. accounts for 84.1% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2019 at $32,471 and has fallen 98.7% since, to $438 in 2025.
Across 152 payments — averaging $504.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Exactech, Inc.$64K
- Medical Device Business Services, Inc.$9K
- Johnson & Johnson$928
- Stryker$588
- Ferring Pharmaceuticals Inc.$481
- Smith+Nephew$262
- plus $1K from 14 others
Across 3 payments — averaging $25,364 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Exactech, Inc.$76K
What the payments were for
- Consulting fees$55,29972%
- Travel & lodging$6,9469%
- Food & beverage$14,36719%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Exactech, Inc. | 67 | $64,454 |
| Medical Device Business Services, Inc. | 10 | $8,756 |
| Johnson & Johnson(2 entities) | 12 | $928 |
| Stryker | 4 | $588 |
| Ferring Pharmaceuticals Inc. | 32 | $481 |
| Smith+Nephew | 3 | $262 |
| Encore Medical, LP | 3 | $250 |
| Biocomposites Inc | 2 | $181 |
| Sanara Medtech Inc. | 2 | $159 |
| Medacta USA, Inc. | 1 | $150 |
| Mimedx Group, Inc. | 1 | $142 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $60 |
| Radius Health, Inc. | 3 | $39 |
| Pacira Therapeutics, Inc. | 2 | $29 |
| Nalu Medical, Inc. | 1 | $28 |
| Zimmer Biomet | 1 | $24 |
| Orthalign Inc | 1 | $22 |
| Curonix LLC | 1 | $21 |
| Innovation Technologies Inc | 1 | $19 |
| Medtronic | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NOVATION HIP$39,285
- ALTEON$21,855
- ATTUNE$8,794
- Kincise$5,849
- Velys$5,849
- Kincise Surgical Automated System$2,700
- VELYS Hip Navigation$2,700
- EQUINOXE$1,729
- TRULIANT$428
- MAKO$413
- ACTIS$376
- OR3O Dual Mobility$251
- OPTETRAK$163
- TRIATHLON$159
- Stimulan$154
- GMK Sphere Revision System$150
- REAL INTELLIGENCE$130
- CellerateRx$124
- POLARSTEM$120
- R3 ACETABULAR$120
How this compares
$76,612 in reported general payments places this provider in the 85th percentile of 381 orthopaedic surgery providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 15 | $9,250 |
| Oxycodone Hcl | 85 | $691 |
| Cephalexin | 43 | $429 |
| Ondansetron Hcl | 33 | $342 |
| Pantoprazole Sodium | 58 | $325 |
| Celecoxib | 19 | $286 |
| Amoxicillin | 229 | $265 |
| Meloxicam | 102 | $260 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $171 |
| Diclofenac Sodium | 12 | $171 |
| Ondansetron OdtOndansetron | 21 | $151 |
| Hydromorphone Hcl | 14 | $132 |
| Doxycycline Hyclate | 14 | $120 |
| Mupirocin | 19 | $97 |
| Dexamethasone | 41 | $68 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $928 | $9,25015 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 381 orthopaedic surgery providers in Tennessee.
Other orthopaedic surgery in Nashville
- Jefferson MorrisonNashville$678K
- Gregory PolkowskiNashville$526K
- Matthew WillisNashville$498K
- Michael ChristieNashville$474K
- David DeboerNashville$448K
- Rudolph GlattesNashville$444K
- John MartinNashville$212K
- Nicholas StrasserNashville$184K
- Jeffrey HodrickNashville$173K
- Brian DierckmanNashville$172K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.